Mioflazine (di(hydrochloride) hydrate) 

Mioflazine dihydrochloride hydrate is a nucleoside transport inhibitor with sleep-improving activity. Mioflazine dihydrochloride hydrate helps maintain the mechanical function of the left ventricle and significantly improves the heart's recovery ability after global ischemia at new temperatures. The application of Mioflazine dihydrochloride hydrate has shown that it has an important protective effect on recovery after cardiac injury^[1].

666.41

C₂₉H₃₄Cl₄F₂N₄O₃

79467-24-6

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Wauquier A, et al. Sleep improvement in dogs after oral administration of mioflazine, a nucleoside transport inhibitor. Psychopharmacology (Berl). 1987;91(4):434-9.  [Content Brief]

  [2]. Mioflazine, a potentially protective drug against ischaemic damage: a study in dogs  [Content Brief]

  [3]. Pirovano IM, et al. Inhibition of nucleoside uptake in human erythrocytes by a new series of compounds related to lidoflazine and mioflazine. Eur J Pharmacol. 1990 Dec 15;189(6):419-22.  [Content Brief]